U.S. RESEARCH ROUNDUP-Armada Hoffler Properties, Morphic Holding, Solid Biosciences

Reuters07-15

July 15 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Armada Hoffler Properties, Morphic Holding and Solid Biosciences, on Monday.

HIGHLIGHTS

* Armada Hoffler Properties Inc : Jefferies cuts to hold from buy

* Morphic Holding Inc : Jefferies cuts to hold from buy

* Solid Biosciences Inc : JP Morgan raises to overweight from neutral

* Valero Energy Corp : Jefferies raises target price to $191 from $184

* Wells Fargo & Co : Jefferies cuts target price to $62 from $64

Following is a summary of research actions on U.S. companies reported by Reuters on Monday. Stock entries are in alphabetical order.

* Armada Hoffler Properties Inc : Jefferies cuts target price to $11 from $13

* Armada Hoffler Properties Inc : Jefferies cuts to hold from buy

* Atlas Energy Solutions Inc : Piper Sandler cuts target price to $27 from $29

* Baker Hughes Co : Piper Sandler cuts target price to $44 from $45

* Bank of New York Mellon Corp : Barclays raises target price to $75 from $68

* BlackRock : TD Cowen cuts target price to $966 from $969

* Blackstone Inc : JP Morgan raises target price to $101 from $100

* Cactus Inc : Piper Sandler cuts target price to $54 from $55

* Carvana Co : BTIG initiates coverage with buy rating; target price $155

* Championx Corp : Piper Sandler cuts target price to $33 from $40

* Citigroup : Piper Sandler raises target price to $73 from $70

* Core Laboratories Inc : Piper Sandler cuts target price to $17 from $18

* Electronic Arts Inc : JP Morgan raises target price to $155 from $148

* Halliburton Co : Piper Sandler cuts target price to $46 from $49

* Helmerich and Payne Inc : Piper Sandler cuts target price to $36 from $39

* JP Morgan : Barclays raises target price to $217 from $212

* JP Morgan : CFRA raises target price by $15 to $230

* JP Morgan : Piper Sandler raises target price to $230 from $220

* KLX Energy Services Holdings Inc : Piper Sandler cuts target to $4.5 from $6.5

* Legend Biotech Corp : TD Cowen cuts target price to $67 from $71

* Liberty Energy Inc : Piper Sandler cuts target price to $25 from $28

* Marathon Petroleum Corp : Jefferies raises target price to $231 from $222

* Molson Coors Beverage Co : JP Morgan cuts target price to $54 from $60

* Morphic Holding Inc : Jefferies cuts target price to $57 from $60

* Morphic Holding Inc : Jefferies cuts to hold from buy

* Nov Inc : Piper Sandler cuts target price to $20 from $22

* Nurix Therapeutics Inc : JP Morgan raises target price to $34 from $31

* Oil States International Inc : Piper Sandler cuts target price to $5.5 from $7.5

* Patterson-UTI Energy Inc : Piper Sandler cuts target price to $12 from $14

* Profrac Holding Corp : Piper Sandler cuts target price to $9 from $11

* Ranger Energy Services Inc : Piper Sandler cuts target price to $12 from $13

* Slb : Piper Sandler cuts target price to $66 from $71

* Smart Sand Inc : Piper Sandler cuts target price to $2.25 from $2.75

* Solid Biosciences Inc : JP Morgan raises target price to $15 from $10

* Solid Biosciences Inc : JP Morgan raises to overweight from neutral

* Trade Desk Inc : Oppenheimer raises target price to $120 from $105

* Ulta Beauty Inc : Oppenheimer cuts target price to $450 from $475

* Valero Energy Corp : Jefferies raises target price to $191 from $184

* W R Berkley Corp : TD Cowen cuts target price to $68 from $68.67

* Wells Fargo & Co : Jefferies cuts target price to $62 from $64

* Williams Companies Inc : CIBC raises target price to $44 from $39

(Compiled by Bengaluru Newsroom)

((Diaries@thomsonreuters.com))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment